The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis

Sexually Transmitted Diseases

Volumn 36, Issue 11, 2009, Pages 711-713

  Bunge, Katherine E ^a   Beigi, Richard H ^a   Meyn, Leslie A ^b   Hillier, Sharon L ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; METRONIDAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; RETREATMENT; VAGINITIS;

ADMINISTRATION, TOPICAL; ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; METRONIDAZOLE; RECURRENCE; TREATMENT FAILURE; TREATMENT OUTCOME; VAGINOSIS, BACTERIAL;

EID: 70350765091     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181af6cfd     Document Type: Article

References (14)

1. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007; 34:864-869.
2. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
3. Sexually Transmitted Diseases: Treatment Guidelines 2006. Available at: http://www.cdc.gov/std/treatment/2006/vaginal-discharge. htm#vagdis2. Accessed February 1, 2009.
4. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193:1478-1486.
5. Livengood CH 3rd, McGregor JA, Soper DE, et al. Bacterial vaginosis: Efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol 1994; 170:759-764.
6. Voorspoels J, Casteels M, Remon JP, et al. Local treatment of bacterial vaginosis with a bioadhesive metronidazole tablet. Eur J Obstet Gynecol Reprod Biol 2002; 105:64-66.
7. Beigi RH, Austin MN, Meyn LA, et al. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004; 191:1124-1129.
8. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22.
9. Eschenbach DA. Bacterial vaginosis: Resistance, recurrence, and/or reinfection? Clin Infect Dis 2007; 44:220-221.
10. Hillier SL, Lipinski C, Briselden AM, et al. Efficacy of intravag-inal 0.75% metronidazole gel for the treatment of bacterial vagi-nosis. Obstet Gynecol 1993; 81:963-967.
11. Schwebke JR, Desmond RA. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis 2007; 44:213-219.
12. Yen S, Shafer MA, Moncada J, et al. Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military. Obstet Gynecol 2003; 102:927-933.
13. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006; 194:1283-1289.
14. Taha TE, Kumwenda NI, Kafulafula G, et al. Intermittent intra-vaginal antibiotic treatment of bacterial vaginosis in HIV-unin-fected and-infected women: A randomized clinical trial. PLoS Clin Trial 2007; 2:e10.